NEW YORK (Reuters Health) – Excessive intake of fructose can increase blood pressure and induce other features of the metabolic syndrome, according to study findings presented Wednesday at…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – When metformin and a sulphonylurea or a glinide fail to bring type 2 diabetes under control, adding pioglitazone may do the trick, French…
NEW YORK (Reuters Health) – In patients with high-risk acute coronary syndromes (ACS) without ST-segment elevation, delaying intervention until the next working day does not appear to pose…
NEW YORK (Reuters Health) – A low-carbohydrate, Mediterranean-style diet is more effective than a conventional low-fat, calorie restricted diet for patients with type II diabetes, according to results…
NEW YORK (Reuters Health) – Insulin can be safely and effectively used as a first-line treatment, in combination with metformin, in patients with newly diagnosed type 2 diabetes,…
In one of the longest-term randomized trials of its kind, researchers compared the effects of a Mediterranean-style diet versus a typical low-fat diet for diabetes management. The trial…
NEW YORK (Reuters Health) – Prior research has linked the thiazolidinediones pioglitazone and rosiglitazone with an increased risk of heart failure, myocardial infarction, and death, but new research…
NEW YORK (Reuters Health) – Although spontaneous reperfusion during percutaneous angiography for treatment of ST-segment myocardial infarction (STEMI) occurs less often in patients with diabetes than in nondiabetics,…